History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
- PMID: 33841175
- PMCID: PMC8027332
- DOI: 10.3389/fphys.2021.637999
History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
Abstract
Mathematical biology and pharmacology models have a long and rich history in the fields of medicine and physiology, impacting our understanding of disease mechanisms and the development of novel therapeutics. With an increased focus on the pharmacology application of system models and the advances in data science spanning mechanistic and empirical approaches, there is a significant opportunity and promise to leverage these advancements to enhance the development and application of the systems pharmacology field. In this paper, we will review milestones in the evolution of mathematical biology and pharmacology models, highlight some of the gaps and challenges in developing and applying systems pharmacology models, and provide a vision for an integrated strategy that leverages advances in adjacent fields to overcome these challenges.
Keywords: QSP modeling; bioinformatics; computational biology; data science; drug development; systems biology; systems pharmacology.
Copyright © 2021 Azer, Kaddi, Barrett, Bai, McQuade, Merrill, Piccoli, Neves-Zaph, Marchetti, Lombardo, Parolo, Immanuel and Baliga.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.Pharmacol Res. 2017 Oct;124:20-33. doi: 10.1016/j.phrs.2017.07.015. Epub 2017 Jul 19. Pharmacol Res. 2017. PMID: 28735000 Review.
-
Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):39-50. doi: 10.1007/s10928-021-09785-6. Epub 2021 Oct 12. J Pharmacokinet Pharmacodyn. 2022. PMID: 34637069 Free PMC article. Review.
-
Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.J Pharm Sci. 2024 Jan;113(1):11-21. doi: 10.1016/j.xphs.2023.10.032. Epub 2023 Oct 26. J Pharm Sci. 2024. PMID: 37898164 Review.
-
Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.Methods Mol Biol. 2022;2486:71-86. doi: 10.1007/978-1-0716-2265-0_5. Methods Mol Biol. 2022. PMID: 35437719
-
From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.Clin Pharmacol Ther. 2023 May;113(5):963-972. doi: 10.1002/cpt.2770. Epub 2022 Nov 10. Clin Pharmacol Ther. 2023. PMID: 36282521 Review.
Cited by
-
Perspectives on training quantitative systems pharmacologists.CPT Pharmacometrics Syst Pharmacol. 2022 Jun;11(6):669-672. doi: 10.1002/psp4.12783. Epub 2022 Apr 7. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35388628 Free PMC article. No abstract available.
-
Delivering on the promise of protein degraders.Nat Rev Drug Discov. 2023 May;22(5):410-427. doi: 10.1038/s41573-023-00652-2. Epub 2023 Feb 21. Nat Rev Drug Discov. 2023. PMID: 36810917 Review.
-
Teaching computational systems biology with an eye on quantitative systems pharmacology at the undergraduate level: Why do it, who would take it, and what should we teach?Front Syst Biol. 2022;2:1044281. doi: 10.3389/fsysb.2022.1044281. Epub 2022 Nov 25. Front Syst Biol. 2022. PMID: 36866242 Free PMC article.
-
Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model.Cancers (Basel). 2023 May 13;15(10):2750. doi: 10.3390/cancers15102750. Cancers (Basel). 2023. PMID: 37345087 Free PMC article.
-
Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager.Front Pharmacol. 2023 Jun 20;14:1163432. doi: 10.3389/fphar.2023.1163432. eCollection 2023. Front Pharmacol. 2023. PMID: 37408756 Free PMC article.
References
-
- Abrams R., Kaddi C. D., Tao M., Leiser R. J., Simoni G., Reali F., et al. . (2020). A quantitative systems pharmacology model of Gaucher disease type 1 provides mechanistic insight into the response to substrate reduction therapy with eliglustat. CPT Pharmacometrics Syst. Pharmacol. 9, 374–383. 10.1002/psp4.12506, PMID: - DOI - PMC - PubMed
-
- Azer K., Michelini S., Giampiccolo S., Parolo S., Leonardelli L., Lombardo R., et al. . (2019). TB knowledgebase: interactive application for extracting knowledge from the TB literature to inform TB drug and vaccine development. Int. J. Tuberc. Lung Dis. 22:S592.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources